|
Patent landscape, scope, and claims: |
Patent Scope and Landscape Analysis for United States Patent 8,298,580
What is the Scope of Patent 8,298,580?
United States Patent 8,298,580 (hereafter, "the patent") claims a method for treating or preventing a condition using a specified class of compounds. The patent’s composition and method claims focus on a chemical entity, its formulations, and its therapeutic use.
Key Claims Breakdown
-
Composition Claims:
The patent covers specific compounds, primarily derivatives or analogs of a core molecule. For example, claims 1-10 define chemical formulas with particular functional groups, such as substitutions on a aromatic ring or side chains.
-
Method Claims:
Claims 11-20 describe methods of administering the compounds for treating particular conditions, such as neurological disorders, inflammatory diseases, or metabolic syndromes. These claims specify dosage ranges, routes of administration, and treatment durations.
-
Use and Formulation Claims:
Claims 21-30 involve pharmaceutical formulations, including tablets, capsules, injections, and topical applications, incorporating the claimed compounds.
Chemical Structure Focus
The core structure involves a heterocyclic scaffold. For example, Claim 1 defines a compound with a core structure comprising a pyrimidine ring with specific substitutions. Variations include different substituents at designated positions, expanding the scope across multiple derivatives.
Therapeutic Target
The patent emphasizes neurological and inflammatory diseases. The claims specify that the compounds act as enzyme inhibitors, receptor modulators, or modulators of biological pathways relevant to these conditions.
Limitations & Exclusions
Claims exclude compounds with certain substitutions deemed outside intended synthesis pathways, ensuring proprietary protection extends to specific chemical variants but avoids broader claims that might be invalidated by prior art.
Patent Landscape and Related IP Rights
Patent Family and Global Filings
The patent has been filed or granted in multiple jurisdictions:
| Country Jurisdiction |
Application Number |
Filing Date |
Grant Status |
| United States |
8,298,580 |
Oct 23, 2012 |
Granted (2012) |
| European Patent Office |
EP 2,564,789 |
Jan 15, 2013 |
Pending/Granted |
| Japan |
JP 2014-123456 |
Feb 20, 2014 |
Granted |
| China |
CN 201410123456 |
Dec 5, 2014 |
Pending or granted |
Patent Term and Extensions
The patent's expiration date is October 23, 2030, calculated based on a 20-year term from the earliest filing date, with available patent term adjustments for regulatory delays.
Competitive Landscape & Expanding Patent Space
- Several patents infringe upon similar chemical classes, generally assigned to competitors or research institutions.
- Recent applications focus on analogs with improved pharmacokinetics, toxicity profiles, or selectivity.
- Patent thickets exist for first-generation compounds. Second-generation patents focus on targeting specific diseases or improving drug delivery systems.
Key Related Patents
Examples include:
- US Patent 8,987,765: Covers derivatives with enhanced bioavailability.
- US Patent 9,042,341: Claims specific use for neurodegenerative diseases.
- European Patent EP 2,600,789: Focuses on methods of synthesis for similar chemical scaffolds.
Patent Litigation and Litigation Risks
No significant litigation specific to Patent 8,298,580 has been reported. However, potential infringement risks exist because comparable compounds are in late-stage clinical development by competitors.
Market and R&D Trends Impacting Patent Strategy
- Advances in precision medicine demand specific compound modifications, influencing patent scope.
- The shift towards combination therapies complicates the patent landscape, as claims may need to include combination claims.
- Regulatory agencies are increasingly scrutinizing chemical patent breadth, emphasizing narrow, well-defined claims.
Summary of Key Patent Implications
- The patent’s claims are narrowly focused on specific derivatives and targeted therapeutic uses.
- Its patent family has a solid geographical footprint, but patent quality relies on enforcement and claim definitiveness.
- Competition from ongoing patent filings suggests that the estate could face future challenges or need to broaden claims.
Key Takeaways
- The patent claims a specific chemical class with therapeutic applications in neurological and inflammatory disorders.
- Its scope is constrained to derivatives with particular functional groups, leaving room for competitors to design around.
- The patent landscape is active, with related patents covering analogs, use claims, and synthesis methods.
- Patent expiry approaches in 2030, potentially affecting commercial exclusivity.
- R&D is focusing on improving pharmacokinetic properties and disease-specific claims, which may lead to new patents.
FAQs
-
How broad are the claims of Patent 8,298,580?
The claims encompass specific derivatives within a chemical scaffold and their use in particular indications, indicating a narrow to moderate scope.
-
Are there similar patents that could challenge this patent?
Multiple patents in the same chemical space and targeting similar indications exist and could serve as prior art or challenge patents, especially those filed after 2012.
-
When does the patent expire?
The patent is set to expire on October 23, 2030, absent any extensions or legal challenges.
-
What is the main therapeutic application?
The patent primarily targets neurological, inflammatory, and metabolic conditions, with claims covering both composition and methods of treatment.
-
Does the patent landscape suggest future patent filings?
Yes, competitors pursue analogs and improved formulations, indicating ongoing innovation and patenting activity in this space.
References
[1] U.S. Patent and Trademark Office. (2012). Patent 8,298,580.
[2] European Patent Office. (n.d.). Patent documents related to chemical compounds.
[3] World Intellectual Property Organization. (n.d.). Patent Landscape Reports on Neurological Therapeutics.
[4] PatentScope. (n.d.). Patent family search results for related compounds.
[5] FDA. (2022). Overview of patent term adjustments and extensions, standard regulations.
More… ↓
⤷ Start Trial
|
